131 related articles for article (PubMed ID: 32302048)
21. Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin.
Sivaramakrishnan V; Shilpa PN; Praveen Kumar VR; Niranjali Devaraj S
Chem Biol Interact; 2008 Jan; 171(1):79-88. PubMed ID: 17950263
[TBL] [Abstract][Full Text] [Related]
22. 24-hour rhythms in oxidative stress during hepatocarcinogenesis in rats: effect of melatonin or alpha-ketoglutarate.
Subramanian P; Dakshayani KB; Pandi-Perumal SR; Trakht I; Cardinali DP
Redox Rep; 2008; 13(2):78-86. PubMed ID: 18339250
[TBL] [Abstract][Full Text] [Related]
23. Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats.
Sivalokanathan S; Ilayaraja M; Balasubramanian MP
Mol Cell Biochem; 2006 Jan; 281(1-2):87-93. PubMed ID: 16328960
[TBL] [Abstract][Full Text] [Related]
24. Anti cancerous efficacy of Ayurvedic milk extract of Semecarpus anacardium nuts on hepatocellular carcinoma in Wistar rats.
Joseph JP; Raval SK; Sadariya KA; Jhala M; Kumar P
Afr J Tradit Complement Altern Med; 2013; 10(5):299-304. PubMed ID: 24311839
[TBL] [Abstract][Full Text] [Related]
25. Curcumin: a unique antioxidant offers a multimechanistic approach for management of hepatocellular carcinoma in rat model.
Ahmed HH; Shousha WG; Shalby AB; El-Mezayen HA; Ismaiel NN; Mahmoud NS
Tumour Biol; 2015 Mar; 36(3):1667-78. PubMed ID: 25371072
[TBL] [Abstract][Full Text] [Related]
26. Effect of diosmin on apoptotic signaling molecules in N-nitrosodiethylamine-induced hepatocellular carcinoma in experimental rats.
Perumal S; Langeshwaran K; Selvaraj J; Ponnulakshmi R; Shyamaladevi B; Balasubramanian MP
Mol Cell Biochem; 2018 Dec; 449(1-2):27-37. PubMed ID: 29479636
[TBL] [Abstract][Full Text] [Related]
27. Curative effect of Amorphophallus campanulatus (Roxb.) Blume. tuber on N-nitrosodiethylamine- induced hepatocellular carcinoma in rats.
Ansil PN; Nitha A; Prabha SP; Latha MS
J Environ Pathol Toxicol Oncol; 2014; 33(3):205-18. PubMed ID: 25272059
[TBL] [Abstract][Full Text] [Related]
28. Protective role of fucoxanthin in diethylnitrosamine-induced hepatocarcinogenesis in experimental adult rats.
Jin X; Zhao T; Shi D; Ye MB; Yi Q
Drug Dev Res; 2019 Mar; 80(2):209-217. PubMed ID: 30379338
[TBL] [Abstract][Full Text] [Related]
29. Nelumbo nucifera leaf extract treatment attenuated preneoplastic lesions and oxidative stress in the livers of diethylnitrosamine-treated rats.
Horng CT; Huang CW; Yang MY; Chen TH; Chang YC; Wang CJ
Environ Toxicol; 2017 Nov; 32(11):2327-2340. PubMed ID: 28804948
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of yellow tea extract on N-nitrosodiethylamine-induced liver carcinogenesis.
Kujawska M; Ewertowska M; Adamska T; Ignatowicz E; Gramza-Michałowska A; Jodynis-Liebert J
Pharm Biol; 2016 Sep; 54(9):1891-900. PubMed ID: 26839940
[TBL] [Abstract][Full Text] [Related]
31. Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway.
Verma A; Singh D; Anwar F; Bhatt PC; Al-Abbasi F; Kumar V
Inflammopharmacology; 2018 Feb; 26(1):133-146. PubMed ID: 28608141
[TBL] [Abstract][Full Text] [Related]
32. Phyllanthus amarus extract administration increases the life span of rats with hepatocellular carcinoma.
Rajeshkumar NV; Kuttan R
J Ethnopharmacol; 2000 Nov; 73(1-2):215-9. PubMed ID: 11025159
[TBL] [Abstract][Full Text] [Related]
33. Antiproliferative potential of gallic acid against diethylnitrosamine-induced rat hepatocellular carcinoma.
Jagan S; Ramakrishnan G; Anandakumar P; Kamaraj S; Devaki T
Mol Cell Biochem; 2008 Dec; 319(1-2):51-9. PubMed ID: 18629614
[TBL] [Abstract][Full Text] [Related]
34. OMA1520 and OMA1774, novel 1,2,4-triazole bearing analogs of combretastatin A-4, inhibit hepatocellular carcinoma: Histological and immunohistochemical studies.
Nofal AE; Shatla IM; Abdelhafeez DA; Mustafa M; Aly OM
Biomed Pharmacother; 2021 Jun; 138():111417. PubMed ID: 33752057
[TBL] [Abstract][Full Text] [Related]
35. Novel 1,2,4-triazole derivatives as antitumor agents against hepatocellular carcinoma.
Radwan RR; Zaher NH; El-Gazzar MG
Chem Biol Interact; 2017 Aug; 274():68-79. PubMed ID: 28693887
[TBL] [Abstract][Full Text] [Related]
36. Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
Ramakrishnan G; Augustine TA; Jagan S; Vinodhkumar R; Devaki T
Exp Oncol; 2007 Mar; 29(1):39-44. PubMed ID: 17431387
[TBL] [Abstract][Full Text] [Related]
37. Ellagic Acid Holds Promise Against Hepatocellular Carcinoma in an Experimental Model: Mechanisms of Action.
Zaazaa AM; Lokman MS; Shalby AB; Ahmed HH; El-Toumy SA
Asian Pac J Cancer Prev; 2018 Feb; 19(2):387-393. PubMed ID: 29479987
[TBL] [Abstract][Full Text] [Related]
38. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
39. In-vitro and in-vivo investigation of amygdalin, metformin, and combination of both against doxorubicin on hepatocellular carcinoma.
Mamdouh AM; Khodeer DM; Tantawy MA; Moustafa YM
Life Sci; 2021 Nov; 285():119961. PubMed ID: 34536497
[TBL] [Abstract][Full Text] [Related]
40. INHIBITORY EFFECT OF TETRAMETHYLPYRAZINE ON HEPATOCELLULAR CARCINOMA: POSSIBLE ROLE OF APOPTOSIS AND CELL CYCLE ARREST.
Cao J; Miao Q; Zhang J; Miao S; Bi L; Zhang S; Yang Q; Zhou X; Zhang M; Xie Y; Wang S
J Biol Regul Homeost Agents; 2015; 29(2):297-306. PubMed ID: 26122217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
